Federal Register Notice: FDA has determined that Moban (molindone HCl) tablets (5 mg, 10 mg, 25 mg, 50 mg, and 100 mg) and capsules (5 mg, 10 mg, and 25 mg) were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve ANDAs for molindone HCl tablets and capsules if all other legal and regulatory requirements are met. To view this notice, click here.
